US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.890
  • -0.057-6.06%
Close 02/23 16:00 ET
  • 0.920
  • +0.030+3.37%
Post 19:42 ET
2.64MMarket Cap0.12P/E (TTM)

Agile Therapeutics Key Stats

EPS
According to the latest financial report of Agile Therapeutics, the latest earnings per share (TTM) for the company is -0.27. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about Agile Therapeutics's free cash flow? The latest report shows it as 365.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Agile Therapeutics shows that the company's current ratio is 0.57, indicating healthy liquidity.

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Agile Therapeutics, the quick ratio is 0.36, indicating that the company can meet its short-term debt obligations.

Quarterly

Loading...

ROE
Want to learn more about the financial health of Agile Therapeutics? The latest ROE figure is -1.10K%, indicating that the company has stable profitability.

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Agile Therapeutics, the total asset return on investment (ROA) is -6.81%.

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Agile Therapeutics's latest financial report to see how their gross margin is doing - currently at 62.82%.

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Agile Therapeutics, the net profit margin is -11.99%, which is a good sign for its profitability.

Quarterly

Loading...

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg